68Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer

被引:0
|
作者
Jonathan Damjanovic
Jan-Carlo Janssen
Christian Furth
Gerd Diederichs
Thula Walter
Holger Amthauer
Marcus R. Makowski
机构
[1] Department of Radiology,
[2] Charité,undefined
[3] Department of Nuclear Medicine,undefined
[4] Charité,undefined
[5] King’s College London,undefined
[6] Division of Imaging Sciences,undefined
来源
关键词
Lung metastasis, Pulmonary opacity, PSMA, PET/CT, Prostate cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] 68Ga-PSMA-PET/CT as a changing practice tool in biochemically recurrent prostate cancer
    Domingues, P. M.
    Abreu, T.
    Siqueira, M. B.
    Marinho, G.
    Rosa, D.
    Cottas, H.
    Araujo, L. H.
    Herchenhorn, D.
    Peixoto, F. A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Prediction of the Gleason Score of Prostate Cancer Patients Using 68Ga-PSMA-PET/CT Radiomic Models
    Vosoughi, Zahra
    Emami, Farshad
    Vosoughi, Habibeh
    Hajianfar, Ghasem
    Hamzian, Nima
    Geramifar, Parham
    Zaidi, Habib
    JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING, 2024, 44 (05) : 711 - 721
  • [23] The significance of nomograms for predicting node metastasis in 68ga-PSMA-PET/CT in prostate cancer
    Onal, C.
    Guler, O. C.
    Torun, N.
    Reyhan, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S623 - S623
  • [24] 68Ga-PSMA-PET/CT Has a Role in Detecting Prostate Cancer Lesions in Patients with Recurrent Disease
    Fitzpatrick, Claire
    Lynch, Olwyn
    Marignol, Laure
    ANTICANCER RESEARCH, 2017, 37 (06) : 2753 - 2760
  • [25] 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
    Bluemel, Christina
    Krebs, Markus
    Polat, Buelent
    Linke, Fraenze
    Eiber, Matthias
    Samnick, Samuel
    Lapa, Constantin
    Lassmann, Michael
    Riedmiller, Hubertus
    Czernin, Johannes
    Rubello, Domenico
    Bley, Thorsten
    Kropf, Saskia
    Wester, Hans-Juergen
    Buck, Andreas K.
    Herrmann, Ken
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 515 - 521
  • [26] LCerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT
    Chan, Mico
    Hsiao, Edward
    Turner, Jennifer
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : 193 - 194
  • [27] The IMPACT of 68GA-PSMA-PET in definitive radiotherapy planning for prostate cancer patients.
    Onal, Cem
    Torun, Nese
    Yildrim, Berna Akkus
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [28] Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT
    Yin, Charlotte
    Ho, Bao
    Chan, Lyn
    Emmett, Louise
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E382 - E384
  • [29] Comparison between 68Ga-PSMA-PET/CT and mpMRI for radiotherapy planning in primary prostate cancer
    Spohn, S.
    Jaegle, C.
    Bettermann, A. S.
    Kiefer, S.
    Jilg, C. A.
    Kranz-Rudolph, J.
    Fassbender, T. F.
    Bronsert, P.
    Nicolay, N. H.
    Bock, M.
    Ruf, J.
    Benndorf, M.
    Grosu, A. L.
    Zamboglou, C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S104 - S104
  • [30] Impact of 68Ga-PSMA-PET/CT to drive targeted therapies in biochemical relapse prostate cancer
    Paschetta, C.
    Skanjeti, A.
    Sotlar, W.
    Giammarile, F.
    Kubinyi, J.
    Vondrak, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S529 - S530